PCRX
Pacira BioSciences, Inc.Company with tickers: PCRX
Market Cap
$947.89M
Shares Outstanding
39,347,924
CIK
1396814
CUSIP
695127100
13F Activity (30d)
8 filings
4 filers
Website
Visit website
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Thomas Wiggans | Class III director | Appointed | 2026-06-11 |
| Samit Hirawat | Class III director | Appointed | 2026-06-11 |
| Christopher J. Christie | Class III director | Appointed | 2026-06-11 |